Redesign of a rapid, low‐cost HPV typing assay to support risk‐based cervical screening and management

Cervical screening during the COVID-19 pandemic: optimising recovery strategies

(2021) Alejandra Castanon et al.   Lancet Public Health

An Isothermal, Multiplex Amplification Assay for Detection and Genotyping of Human Papillomaviruses in Formalin-Fixed, Paraffin-Embedded Tissues

(2020) Yi-Wei Tang et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Evaluation of an isothermal amplification HPV detection assay for primary cervical cancer screening

(2020) Wei Zhang et al.   Infectious Agents and Cancer

Design and feasibility of a novel program of cervical screening in Nigeria: self-sampled HPV testing paired with visual triage

(2020) Kanan T. Desai et al.   Infectious Agents and Cancer

A rapid, high-volume cervical screening project using self-sampling and isothermal PCR HPV testing

(2020) Andrew Goldstein et al.   Infectious Agents and Cancer

Designing low-cost, accurate cervical screening strategies that take into account COVID-19: a role for self-sampled HPV typing

(2020) Kayode Olusegun Ajenifuja et al.   Infectious Agents and Cancer

BAYESIAN ANALYSIS OF BASELINE RISK OF CIN2 AND ≥CIN3 BY HPV GENOTYPE IN A EUROPEAN REFERRAL COHORT

(2019) Jesper Bonde et al.   INTERNATIONAL JOURNAL OF CANCER

Type-dependent association between risk of cervical intraepithelial neoplasia and viral load of oncogenic human papillomavirus types other than types 16 and 18

(2017) Long Fu Xi et al.   INTERNATIONAL JOURNAL OF CANCER

HPV-based cervical cancer screening- facts, fiction, and misperceptions

(2017) Nicolas Wentzensen et al.   PREVENTIVE MEDICINE

A cohort study of cervical screening using partial HPV typing and cytology triage

(2016) Mark Schiffman et al.   INTERNATIONAL JOURNAL OF CANCER

Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis

(2016) Laia Bruni et al.   Lancet Global Health

A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results

(2015) Mark Schiffman et al.   GYNECOLOGIC ONCOLOGY

Multiple Biopsies and Detection of Cervical Cancer Precursors at Colposcopy

(2015) Nicolas Wentzensen et al.   JOURNAL OF CLINICAL ONCOLOGY

The low risk of precancer after a screening result of human papillomavirus-negative/atypical squamous cells of undetermined significance papanicolaou and implications for clinical management

(2014) Julia C. Gage et al.   CANCER CYTOPATHOLOGY

Judging the carcinogenicity of rare human papillomavirus types

(2014) Jean-Damien Combes et al.   INTERNATIONAL JOURNAL OF CANCER

Reassurance Against Future Risk of Precancer and Cancer Conferred by a Negative Human Papillomavirus Test

(2014) J. C. Gage et al.   JNCI-Journal of the National Cancer Institute

Prevalence of high-risk human papillomavirus and cervical intraepithelial neoplasias in a previously unscreened population-A pooled analysis from three studies

(2012) Partha Basu et al.   INTERNATIONAL JOURNAL OF CANCER

Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer

(2012) Peng Guan et al.   INTERNATIONAL JOURNAL OF CANCER

Don’t Forget HPV-45 in Cervical Cancer ScreeningThe Authors’ Reply

(2011) Wiebren A.A. Tjalma et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: Implications for screen-and-treat strategies

(2011) Julia C. Gage et al.   INTERNATIONAL JOURNAL OF CANCER

Coverage of Cervical Cancer Screening in 57 Countries: Low Average Levels and Large Inequalities

(2008) Emmanuela Gakidou et al.   PLOS MEDICINE